On December 3rd, 2025, BrainScan S.A. signed a strategic distribution agreement with Carebot s.r.o., a leading Czech provider of AI solutions for radiology. The agreement covers the deployment and commercial expansion of the BrainScan CT system – an advanced AI technology for automated brain CT analysis.
This partnership marks a significant step in strengthening BrainScan’s presence across Central Europe. Carebot’s strong regional footprint, established customer base, and deep understanding of radiology workflows create ideal conditions for introducing BrainScan CT to hospitals and medical networks in several new markets. The collaboration is expected to accelerate commercial rollouts and open new revenue opportunities in the coming months.
The product portfolios of the two companies naturally complement each other. BrainScan’s automated brain CT analytics – supporting rapid detection and classification of critical intracranial pathologies – align seamlessly with Carebot’s AI solutions designed for chest X-ray, skeletal radiography, and mammography. Together, these technologies create a comprehensive suite of radiology AI tools that significantly enhance diagnostic support, streamline workflows, and deliver substantial value to healthcare providers.
Carebot s.r.o. is a Czech-based company specializing in medical imaging AI, with solutions already deployed in numerous hospital systems across Central Europe. The company participates in pilot implementations with major partners such as Bristol Myers Squibb and Synektik, demonstrating its capability to deliver scalable and clinically relevant AI technology.
The partnership between BrainScan and Carebot brings together two complementary innovations and sets the foundation for joint expansion in international healthcare markets.
